Illumina’s Goswami to depart

Two people are stepping in to succeed Illumina Inc. (NASDAQ:ILMN) CFO and Chief Strategy and Corporate Development Officer Joydeep Goswami, who will become an adviser to the company on April 15 and depart on July 1. Ankur Dhingra will take on the CFO role, joining Illumina from Summit Therapeutics Inc. (NASDAQ:SMMT), where he also served as CFO. Jakob Wedel, who joined Illumina in October as VP, CEO office, will become chief strategy and corporate development officer.

Immuno-dermatology company  Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) named David Topper CFO. Topper was CFO at Inmagene Biopharmaceuticals Co. Ltd. and succeeds John Smither, who was Arcutis’ CFO from 2019 until 2021, then rejoined as interim CFO last August. ...